Compare CCJ & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCJ | RMD |
|---|---|---|
| Founded | 1987 | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3B | 34.0B |
| IPO Year | 1998 | 1996 |
| Metric | CCJ | RMD |
|---|---|---|
| Price | $87.94 | $222.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $123.92 | ★ $292.56 |
| AVG Volume (30 Days) | ★ 2.6M | 1.0M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | 0.15% | ★ 1.13% |
| EPS Growth | N/A | ★ 9.67 |
| EPS | N/A | ★ 10.43 |
| Revenue | N/A | ★ $2,957,013,000.00 |
| Revenue This Year | $0.12 | $10.60 |
| Revenue Next Year | $12.11 | $7.41 |
| P/E Ratio | $118.32 | ★ $21.27 |
| Revenue Growth | N/A | ★ 13.44 |
| 52 Week Low | $77.70 | $180.27 |
| 52 Week High | $135.24 | $284.87 |
| Indicator | CCJ | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.38 | 47.62 |
| Support Level | $83.65 | $217.10 |
| Resistance Level | $123.86 | $233.94 |
| Average True Range (ATR) | 2.78 | 4.99 |
| MACD | -0.92 | -0.95 |
| Stochastic Oscillator | 1.71 | 37.78 |
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe and is one of those uranium producers. It has three reportable segments: Uranium, Fuel Services, and Westinghouse, deriving maximum revenue from the Westinghouse segment. The Uranium segment involves the exploration for, mining, milling, purchase, and sale of uranium concentrate, while the Fuel Services segment involves the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. Westinghouse Electric Company provides products and services to nuclear reactors, including outage and maintenance services, engineering support, instrumentation and controls equipment, plant modification, and components and parts.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.